BRII BIOSCIENCES BREAKTHROUGH INNOVATION & INSIGHT
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 02 Apr 2026)
What this means for you
Registered since 14 Jan 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Jan 2030: the §8 & §9 renewal).
Record
- Serial number
- 87982217
- Registration number
- 5962396
- Mark type
- Design + words
- Filed
- 09 May 2018
- Published for opposition
- 19 Feb 2019
- Registered
- 14 Jan 2020
- Next maintenance filing
- §8 & §9 renewal, due by 14 Jan 2030 (grace period to 14 Jul 2030)
- Attorney of record
- Scott W. Pink
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceutical and biopharmaceutical drugs and medicines for the treatment of acute and chronic infectious diseases; research and development in the pharmaceutical, life sciences and biotechnology fields
Owner
- BRII BIOSCIENCES LIMITED, San Mateo, CA, KY
- BRII BIOSCIENCES LIMITED, SHANGHAI, KY
- BRII BIOSCIENCES LIMITED, SHANGHAI, KY
- BiiG THERAPEUTICS LIMITED, SHANGHAI, KY
Prosecution history
- 02 Apr 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Apr 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Apr 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jan 2026 — TEAS SECTION 8 & 15 RECEIVED
- 14 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 10 Dec 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Dec 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Oct 2019 — DIVISIONAL PROCESSING COMPLETE
- 16 Oct 2019 — DIVISIONAL REQUEST RECEIVED
- 31 Oct 2019 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 30 Oct 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Oct 2019 — USE AMENDMENT FILED
- 16 Oct 2019 — TEAS REQUEST TO DIVIDE RECEIVED
- 30 Oct 2019 — SOU EXTENSION 1 GRANTED